Summit Financial Wealth Advisors’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.36M | Buy |
10,611
+754
| +8% | +$88.3K | 0.17% | 71 |
|
|
2026
Q1 | $1.19M | Sell |
9,857
-6
| -0.1% | -$693 | 0.17% | 69 |
|
|
2025
Q4 | $1.04M | Sell |
9,863
-161
| -2% | -$15.1K | 0.15% | 76 |
|
|
2025
Q3 | $903K | Buy |
10,024
+345
| +4% | +$28.4K | 0.14% | 70 |
|
|
2025
Q2 | $766K | Buy |
9,679
+872
| +10% | +$69.3K | 0.14% | 72 |
|
|
2025
Q1 | $790K | Sell |
8,807
-767
| -8% | -$71.6K | 0.16% | 67 |
|
|
2024
Q4 | $955K | Sell |
9,574
-62,998
| -87% | -$6.49M | 0.19% | 62 |
|
|
2024
Q3 | $8.24M | Buy |
72,572
+762
| +1% | +$90.5K | 1.55% | 22 |
|
|
2024
Q2 | $8.89M | Sell |
71,810
-2,175
| -3% | -$280K | 1.8% | 17 |
|
|
2024
Q1 | $9.76M | Buy |
73,985
+1,605
| +2% | +$198K | 1.98% | 14 |
|
|
2023
Q4 | $7.89M | Sell |
72,380
-316
| -0.4% | -$32.8K | 1.79% | 18 |
|
|
2023
Q3 | $7.56M | Sell |
72,696
-1,182
| -2% | -$127K | 1.86% | 16 |
|
|
2023
Q2 | $8.52M | Sell |
73,878
-3,242
| -4% | -$368K | 1.97% | 16 |
|
|
2023
Q1 | $8.2M | Sell |
77,120
-79
| -0.1% | -$8.53K | 1.95% | 16 |
|
|
2022
Q4 | $8.57M | Buy |
77,199
+57
| +0.1% | +$5.83K | 2.07% | 15 |
|
|
2022
Q3 | $7.69M | Buy |
77,142
+3,642
| +5% | +$325K | 2.21% | 15 |
|
|
2022
Q2 | $6.65M | Buy |
73,500
+1,633
| +2% | +$145K | 1.59% | 23 |
|
|
2022
Q1 | $5.9M | Buy |
71,867
+4,540
| +7% | +$358K | 1.19% | 30 |
|
|
2021
Q4 | $5.18M | Buy |
67,327
+6,882
| +11% | +$548K | 1% | 29 |
|
|
2021
Q3 | $4.54M | Buy |
60,445
+5,160
| +9% | +$392K | 1.03% | 29 |
|
|
2021
Q2 | $4.3M | Buy |
55,285
+797
| +1% | +$59.3K | 0.97% | 29 |
|
|
2021
Q1 | $4.25M | Buy |
54,488
+2,022
| +4% | +$149K | 1.08% | 27 |
|
|
2020
Q4 | $4.15M | Sell |
52,466
-4,459
| -8% | -$341K | 1.13% | 26 |
|
|
2020
Q3 | $4.17M | Sell |
56,925
-456
| -0.8% | -$35.7K | 1.11% | 26 |
|
|
2020
Q2 | $4.27M | Buy |
57,381
+2,610
| +5% | +$196K | 1.14% | 26 |
|
|
2020
Q1 | $4.2M | Buy |
54,771
+574
| +1% | +$45.1K | 1.32% | 23 |
|
|
2019
Q4 | $4.45M | Buy |
54,197
+409
| +0.8% | +$33.6K | 1.08% | 28 |
|
|
2019
Q3 | $4.33M | Buy |
53,788
+7,629
| +17% | +$611K | 1.06% | 26 |
|
|
2019
Q2 | $3.69M | Buy |
46,159
+10,423
| +29% | +$798K | 0.9% | 31 |
|
|
2019
Q1 | $2.84M | Buy |
35,736
+986
| +3% | +$73.7K | 0.75% | 42 |
|
|
2018
Q4 | $2.53M | Buy |
34,750
+3,518
| +11% | +$248K | 0.82% | 37 |
|
|
2018
Q3 | $2.07M | Buy |
31,232
+7,487
| +32% | +$477K | 0.62% | 47 |
|
|
2018
Q2 | $1.23M | Sell |
23,745
-1,121
| -5% | -$63.2K | 0.41% | 57 |
|
|
2018
Q1 | $1.29M | Buy |
24,866
+3,977
| +19% | +$215K | 0.42% | 56 |
|
|
2017
Q4 | $1.12M | Buy |
20,889
+1,363
| +7% | +$75.6K | 0.39% | 61 |
|
|
2017
Q3 | $1.19M | Buy |
19,526
+2,323
| +14% | +$141K | 0.43% | 60 |
|
|
2017
Q2 | $1.05M | Buy |
17,203
+4,887
| +40% | +$297K | 0.42% | 62 |
|
|
2017
Q1 | $747K | Sell |
12,316
-443
| -3% | -$26.9K | 0.33% | 74 |
|
|
2016
Q4 | $717K | Buy |
12,759
+90
| +0.7% | +$5.27K | 0.32% | 77 |
|
|
2016
Q3 | $754K | Buy |
12,669
+263
| +2% | +$15.4K | 0.33% | 68 |
|
|
2016
Q2 | $682K | Buy |
12,406
+4,258
| +52% | +$227K | 0.28% | 78 |
|
|
2016
Q1 | $411K | Buy |
8,148
+1,110
| +16% | +$54.4K | 0.18% | 100 |
|
|
2015
Q4 | $355K | Buy |
7,038
+4,135
| +142% | +$208K | 0.16% | 98 |
|
|
2015
Q3 | $136K | Hold |
2,903
| – | – | 0.09% | 92 |
|
|
2015
Q2 | $157K | Hold |
2,903
| – | – | 0.1% | 91 |
|
|
2015
Q1 | $164K | Hold |
2,903
| – | – | 0.11% | 75 |
|
|
2014
Q4 | $157K | Buy |
+2,903
| New | +$162K | 0.11% | 76 |
|
Other funds holding MRK
ECSS
Summit Financial Wealth Advisors's MRK Position: Q2 2026 in Review
Summit Financial Wealth Advisors increased its Merck (MRK) stake by 7.6% in Q2 2026, buying an estimated $88.3K and bringing the position to 10,611 shares worth $1.36M. The position accounts for 0.17% of the portfolio, ranked #71.
Summit Financial Wealth Advisors first reported a position in MRK in Q4 2014 and has held it in 47 quarters since. The position peaked at $9.76M in Q1 2024. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Summit Financial Wealth Advisors held 10,611 shares of Merck worth $1.36M as of Q2 2026.
- Summit Financial Wealth Advisors bought 754 Merck shares in Q2 2026, an estimated $88.3K.
- Merck made up 0.17% of Summit Financial Wealth Advisors's portfolio in Q2 2026, its #71 holding.
- Summit Financial Wealth Advisors first reported a position in Merck in Q4 2014 and has held it in 47 quarters since.
- Summit Financial Wealth Advisors's Merck position peaked at $9.76M in Q1 2024.
- 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Summit Financial Wealth Advisors's 13F filing for Q2 2026, filed 15 Jul 2026.